Airway Rod Device to Guide Breathing Tube Placement in Adults With Obesity
Tests a stabilizing rod device to help place a breathing tube in adults with obesity.
Key facts
- Who runs it
- Baylor College of Medicine
- Where
- Houston, United StatesSee the site
- Trial code
- Registry title
- Utilization of Airway Stabilizing Rod to Assist With Laryngeal Mask Airway Guided Fiberoptic Intubation in Adults With Obesity
- Status
- Enrolling by invitation
- People taking part
- 20 people, planned
- Started
- 21 Apr 2025
- Planned end
- 1 Sept 2025
- Type of study
- Interventional
- Treatments tested
- Fiberoptic Assisted Endotracheal Rod Intubation
- Record updated
- 14 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obesity (BMI over 35) who are having planned surgery that needs a breathing tube. It tests a rod that helps place the tube through a laryngeal mask.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- BMI above 35 kg/m2.
Main reasons for not taking part
- Pregnant women
- Newborns
- Children
- People in prison
- People who refuse to take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adult (18-64 yrs),
- Geriatric (65+ yrs)
- BMI > 35 kg/m2
- elective surgery requiring intubation
Who cannot take part
- pregnant woman
- neonates
- children
- incarcerated patient
- patient refusal
Where in United States
- Ben Taub General HospitalHouston, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The FASTER stabilizing rod offers the distinct advantage of intubating through the laryngeal mask airway with a fiberoptic scope via the FASTER stabilizing rod. The device allows for the provider to insert the endotracheal tube (ETT) with visual confirmation using the fiberoptic scope into the trachea. The device then allows for the laryngeal mask airway to be removed while stabilizing the ETT to ensure the ETT does not get dislodged.
Read full original descriptionShow less
The purpose of this protocol is to clinically test the validated prototype that the investigators have built and previously tested in adults with obesity.
The primary aims are to evaluate 1) the time to intubation and 2) the number of intubation attempts. The secondary aim is to note any complications from time to intubation to PACU discharge.
These complications include: Hypoxemia (10% decrease from baseline for 45 seconds)1 Airway trauma (minor) Esophageal intubation Laryngospasm Bronchospasm Oro-pharyngeal bleeding Arrythmia Emesis Epistaxis Dental damage Post-operative sore throat Post-operative hoarseness Accidental extubation during removal of the LMA.
The group in the trial
- Morbid ObesityTreatment being tested
Elective surgery requiring intubation, Age \> 18, BMI \> 35 kg/m2
Treatment: Fiberoptic Assisted Endotracheal Rod Intubation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Utilization of Airway Stabilizing Rod to Assist With Laryngeal Mask Airway Guided Fiberoptic Intubation in Adults With Obesity
- Plain-language title
- Airway Rod Device to Guide Breathing Tube Placement in Adults With ObesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 14 May 2025